-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Barinthus Biotherapeutics plc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q3 2024.
- Barinthus Biotherapeutics plc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$8.11M, a 42.3% increase year-over-year.
- Barinthus Biotherapeutics plc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$57.8M, a 25.1% increase year-over-year.
- Barinthus Biotherapeutics plc. annual Net Income (Loss) Attributable to Parent for 2023 was -$73.3M, a 1473% decline from 2022.
- Barinthus Biotherapeutics plc. annual Net Income (Loss) Attributable to Parent for 2022 was $5.34M.
- Barinthus Biotherapeutics plc. annual Net Income (Loss) Attributable to Parent for 2021 was -$50.9M, a 187% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)